抗衰老与老年痴呆专业委员会是中国药理学会的附属机构，以1998年建立的中国老年性痴呆科学家学会为基础，于2004年由国家民政部批准成立。本专业委员会紧密融合药理学、神经科学、临床医学、药学、流行病学及分子生物学等多领域前沿知识，展现出独特的跨学科融合特色。

在中国药理学会的领导下，本专业委员会始终将学术交流与探索作为核心使命，汇聚了全国抗衰老与老年痴呆研究领域的杰出基础与临床学者。从1998年开始，本专业委员会已经举办了19届全国性抗衰老与老年痴呆学术会议。通过广泛而深入的国内外学术交流与合作，不断推动我国在该领域的基础研究与临床干预水平达到新的高度。同时，我们注重人才培养、科研基地建设以及新药研发与创新工作，为应对人口老龄化带来的挑战贡献科学力量。

本专业委员会充分发挥多学科交叉的优势，以药理学为基石，融合西医与中医的智慧，深入探讨衰老与老年痴呆的复杂发病机制、早期精准诊断方法、有效临床干预策略以及创新药物治疗的新路径与新措施。此外，本专业委员会还积极投身于科普宣传事业，致力于将科学的抗衰老与老年痴呆知识普及至广大民众。每年9月21日国际老年痴呆日，我们都会携手其他学会，组织专家、临床医生和药师共同举办科普宣传和义诊活动，深受广大患者及家属的欢迎，已成为具有广泛影响力和良好口碑的品牌科普活动。

The Committee on Anti-Aging and Alzheimer's Disease, an affiliated institution of the Chinese Pharmacological Society, was formally established in 2004 with approval from the Ministry of Civil Affairs of China. This professional committee evolved from the Chinese Society of Alzheimer's Disease Scientists founded in 1998, and has developed distinctive interdisciplinary characteristics by integrating cutting-edge knowledge across pharmacology, neuroscience, clinical medicine, pharmacy, epidemiology, and molecular biology.

Under the guidance of the Chinese Pharmacological Society, the committee has consistently prioritized academic exchange and scientific exploration, assembling distinguished scholars in both basic and clinical research domains of anti-aging and Alzheimer's disease (AD) nationwide. Since 1998, it has successfully convened 19 national academic conferences on anti-aging and Alzheimer's disease. Through extensive domestic and international collaborations, the committee has significantly advanced fundamental research and clinical intervention capabilities in this field. Concurrently, it emphasizes talent cultivation, research infrastructure development, and innovative drug discovery, thereby providing scientific solutions to address challenges posed by population aging.

Leveraging multidisciplinary synergies with pharmacological foundations, the committee systematically investigates the complex pathogenesis of aging and dementia, develops precision diagnostic methodologies, formulates effective clinical intervention strategies, and explores novel therapeutic approaches integrating Western and Traditional Chinese Medicine paradigms. Furthermore, the committee actively engages in science communication initiatives, particularly through annual public education campaigns coinciding with World Alzheimer's Day on September 21. These collaborative events with partner organizations, featuring expert lectures and free medical consultations by clinicians and pharmacists, have evolved into influential public service programs receiving widespread public recognition.